Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Evotec is a drug discovery alliance. It is focused on rapidly developing innovative drugs and other products with leading pharmaceutical and biotechnology companies. Its partners include Bayer, Boehringer Ingelheim, Genentech and Janssen Pharmaceuticals. In addition, Evotec has product candidates both in clinical and pre-clinical development.
Gilde obtained listed Evotec shares (Frankfurt Stock Exchange: EVT) in 2007 after Evotec acquired the French company Neuro3D for its clinical program in schizophrenia.
More Evotec news
Venture&Growth
SpliceBio
SpliceBio is a Spanish therapeutics company addressing the key limitations of current gene therapy. It harnesses its proprietary Protein Splicing platform to develop next-generation gene therapies, based on engineered inteins pioneered at the Muir Lab at Princeton University. The company
Venture&Growth
Mobia Medical
Mobia Medical is a U.S.-based, growth-stage company commercializing the Vivistim Paired VNS System, an implantable neurostimulation therapy that improves outcomes for chronic ischemic stroke survivors with upper limb motor deficits. Vivistim Paired VNS System is an implantable neurostimulation therapy that
Venture&Growth
Alleviant Medical
Alleviant Medical is a clinical stage medical device company founded in 2017 that has developed a minimally invasive system to treat patients suffering from chronic heart failure who are symptomatic despite appropriate medical therapy. The company has conducted successful first
